Clinical Trial Update: An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib

View source ↗

Summary

This clinical trial update describes an observational real-world study of ALK-positive advanced non-small cell lung cancer patients treated with alectinib, aimi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alecensa (alectinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: NSCLC | Status: ACTIVE_NOT_RECRUITING